Status:
WITHDRAWN
National Wilm's Tumor Study Late Effects
Lead Sponsor:
Emory University
Conditions:
Wilm's Tumor
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5...
Detailed Description
The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Although most people in this study enjoy good ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Previously enrolled in NWTS 5.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00228696
Start Date
September 1 2005
End Date
December 1 2011
Last Update
November 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322